Smithtown Assisted Living
(516) 265-7793
ESC: 6-Month DAPT Non-Inferior to Longer Tx Strategy
(MedPage Today) -- But problems with NIPPON trial highlight challenges of dual antiplatelet therapy research
via
ESC: 6-Month DAPT Non-Inferior to Longer Tx Strategy
by
Newer Post
Older Post
Home